A NEW partnership to speed up the development of treatments for arthritis has been launched, supported by a £7m investment from Oxford’s Kennedy Trust for Rheumatology Research.
The partnership between Oxford University and Birmingham University will be based at the Kennedy Institute of Rheumatology and at the Institute of Translational Medicine in Birmingham.
The alliance between the two universities will develop a network of consultants, nurses and researchers in clinical units along the M40 corridor.
Prof Fiona Powrie, Director of the Kennedy Institute of Rheumatology in Oxford, said: “This exciting initiative will allow us to place basic research at the heart of innovative new clinical trials.”
The partnership will utilise existing research strengths of both universities to speed up the development and testing of new therapies for patients.
The programme will develop and test therapies based on the underlying causes of inflammatory disease.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here